Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/8/2016
CFDA Issues Technical Guidelines for Clinical Trial of Drugs for Pedia...
3/7/2016
Review of Chinese Drug Evaluation and Registration in 2015
3/7/2016
Premiere LI Keqiang Sets Out Direction of Healthcare Reform This Year
3/6/2016
CFDA Issues Plan for Reform of Chemical Drug Registration Classificati...
3/6/2016
Data Snapshot - Chinese Drug Registration Review Acceptance Down But C...
3/4/2016
WuXi AppTec's CMO Subsidiary Opens New cGMP Facility in Changzhou
3/3/2016
State Council Amends the Implementation Regulations of Drug Administra...
3/2/2016
11 More Pharma Companies Withdrew 21 Drug Applications
3/2/2016
IMS: Chinese Retail Pharmacy Sales Up 8.9% in MAT Q3/2015
3/2/2016
Recent Executive Moves
3/2/2016
Chi-Med Initiates Sulfatinib Phase II Clinical Trial in Thyroid Cancer
3/2/2016
Prima BioMed and WuXi Biologics Announce First Dose of Chinese-Manufac...
3/1/2016
CFDA Issues Health Food Registration and Filing Regulation
2/29/2016
Wuxi AppTec, Ping An Bank Line Up to Develop Healthcare Business
2/29/2016
Astrazeneca, CMS Enter Licensing Deals for Plendil and Imdur
2/28/2016
China Issues Five Year Planning Guideline for TCM Development
2/26/2016
CFDA Issues New Policy for Priority Review of Backlogged Drug Registra...
2/26/2016
Wuxi PharmaTech to Spin Off Biologics Arm
2/25/2016
China Pioneer, Polichem Enter Supplemental Agreement for Polimod Sales...
2/25/2016
Recent Executive Moves
2/24/2016
Zubair Ahmed: China Is Top Priority of GSK Consumer Healthcare
2/23/2016
CFDA Issues Draft Document for Clinical Trial Data Inspection
2/23/2016
Zhejiang Jiuzhou Enters API Supply Agreement with Novartis
2/23/2016
Chinese Healthcare Venture Financing Deals Ballooned 106% in 2015
2/23/2016
Shanghai Issues Policy for Centralized Drug Purchase, With Guangdong U...
2/22/2016
BMS's Phase 3 Trial of All-Oral Chronic HCV Regimen Shows High Cure Ra...
2/22/2016
AmCham China's 2016 Business Climate Survey: Optimisms Remain Despite ...
2/22/2016
CFDA Publishes Lists of Drug Approvals in 2015
2/19/2016
IMS: Chinese Hospital Drug Sales Up 6.6% in MAT Q3/2015
2/19/2016
CPIIC: Hospital Drug Drugs in Major Chinese Cities Up 5.8% in Q3/2015
Page:
187
/
334
Total number of articles:
10001
:
[First]
[<<]
[185]
[186]
[187]
[188]
[189]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit